Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Survey: Pharma wants promotional content management systems, but silos abound

Veeva Systems released its 2015 Promotional Content Management System survey, and found that while many in the pharma industry want end-to-end systems to keep track of and disseminate the flood of promotional digital materials being generated, the industry’s capabilities to do so are hampered at this time by a number of factors. Med Ad News […]

Read More »

You probably have herpes, the WHO says

Two-thirds of the world’s population under 50 have the highly infectious herpes virus that causes cold sores around the mouth, the World Health Organization said on Wednesday, in its first estimate of global prevalence of the disease. More than 3.7 billion people under the age of 50 suffer from the herpes simplex virus type 1 […]

Read More »

Arcturus Therapeutics Stands to Collect Up to $1.66 Billion from Rare Disease Pact with Ultragenyx

Novato, Calif.-based Ultragenyx Pharmaceutical Inc. (RARE), announced today that it has inked a research and collaboration deal with San Diego-based Arcturus Therapeutics, Inc.   The two companies will work to identify and develop messenger RNA (mRNA) therapeutics for rare disease targets utilizing Arcturus’ UNA Oligomer chemistry and LUNAR nanoparticle delivery program. Ultragenyx will pay Arcturus […]

Read More »

Rumors Confirmed, Pfizer and Allergan In Talks to Merge

After months of speculation on who Pfizer Inc. (PFE) will attempt to buy are now officially over — sort of. It has been confirmed that Pfizer Inc. and Allergan Plc (AGN), according to the Wall Street Journal, are discussing a potential merger. The two companies have declined to comment.   Analysts have been speculating on […]

Read More »

Valeant’s ambitious plan for its contact lens business

Valeant Pharmaceuticals International has pursued a plan in recent months to dominate the market for specialty contact lenses, according to two people familiar with the company’s approach and some of the company’s communications with its customers.   The Canadian drugmaker’s goal, spelled out to key employees and demonstrated through its actions, has been to acquire […]

Read More »

FDA expands use of Bristol-Myers’ cancer drug Yervoy

The U.S. Food and Drug Administration expanded the use of Bristol-Myers Squibb Co’s skin cancer drug, Yervoy, as an additional therapy for patients with late-stage melanoma. This approval extends Yervoy’s use to patients with stage III melanoma, who have a high risk of recurrence after surgery, the agency said on Wednesday. Due to the potential […]

Read More »

Amgen profit beats Street, issues conservative 2016 forecast

Amgen Inc (AMGN.O) on Wednesday reported much higher-than-expected third-quarter profit, helped by a 30-percent spike in revenue from the rheumatoid arthritis drug Enbrel due to price increases and inventory stocking. The world’s largest biotechnology company raised its full-year earnings forecast on the back of the strong quarter, and issued its first 2016 projections for adjusted […]

Read More »

Fred Kinch Launches Healthcare Advertising Agency

Industry veteran Fred Kinch has launched a new healthcare communications agency this month. Mr. Kinch previously served as Managing Partner and Executive Creative Director at New York-based healthcare ad agency AgencyRx. Kinch Advertising LLC is a full-service, mission-built, independent healthcare advertising agency located in Midtown Manhattan. The agency is primarily focused on creating promotions and […]

Read More »

Sanofi U.S. recalls Auvi-Q injections for severe allergy

French drugmaker Sanofi SA said it was voluntarily recalling all its Auvi-Q injections in the United States to treat patients with severe allergic reactions. The company said on Wednesday its U.S. unit was recalling the injections as they could potentially deliver an inaccurate dose. Auvi-Q is designed to treat anaphylaxis, a potentially fatal allergic reaction, […]

Read More »

Baxter International Brings Aboard Former Covidien Head as Chairman, CEO

DEERFIELD, Ill. – Baxter International tapped José (Joe) Almeida as the company’s new chairman and chief executive officer effective Jan. 1, 2016, the company announced Wednesday.   Almeida, the former president and CEO of Covidien, will take over the Baxter helm when current CEO Robert Parkinson Jr. retires. Almeida, a native of Brazil, will start […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom